ESSA Pharma Inc.
NASDAQ:EPIX
5.74 (USD) • At close October 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.118 | 0.122 | 0.109 | 0.11 | 0 | 0.034 | 0.046 | 0.066 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.118 | -0.122 | -0.109 | -0.11 | 0 | -0.034 | -0.046 | -0.066 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -303.982 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 21.323 | 24.415 | 24.259 | 12.146 | 6.696 | 4.873 | 5.726 | 13.06 | 4.388 | 0.672 | 1.589 | 0.002 |
| General & Administrative Expenses
| 11.366 | 12.545 | 12.775 | 11.374 | 5.473 | 5.929 | 5.141 | 5.644 | 3.701 | 1.042 | 0.349 | 0 |
| Selling & Marketing Expenses
| 0.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.022 | 0 |
| SG&A
| 11.366 | 12.545 | 12.775 | 11.374 | 5.473 | 5.929 | 5.141 | 5.644 | 3.701 | 1.042 | 0.371 | 0 |
| Other Expenses
| 0 | 1.738 | 0.109 | 0.515 | 0.035 | -0.04 | -0.037 | 0.079 | 1.145 | 0 | 0 | 0 |
| Operating Expenses
| 32.134 | 36.96 | 37.144 | 23.52 | 12.169 | 10.802 | 10.867 | 18.704 | 9.234 | 1.737 | 1.373 | 0.002 |
| Operating Income
| -26.58 | -35.343 | -36.909 | -23.115 | -12.152 | -10.802 | -11.652 | -19.642 | -9.312 | -1.825 | -1.363 | -0.002 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90,516.129 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.007 | 0.128 | 0.069 | -0.619 | 1.749 | 0.111 | 7.269 | 6.653 | 0.743 | 0 | -0.009 | 0 |
| Income Before Tax
| -26.581 | -35.215 | -36.84 | -23.734 | -10.403 | -11.603 | -4.383 | -12.989 | -8.568 | -1.824 | -1.371 | -0.002 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -59,857.143 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.002 | -0.112 | -0.034 | -0.289 | 0.038 | 0.027 | 0.116 | 0.151 | 0.078 | 0.088 | 0 | 0 |
| Net Income
| -26.582 | -35.103 | -36.805 | -23.445 | -10.441 | -11.63 | -4.499 | -13.14 | -8.568 | -1.824 | -1.371 | -0.002 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60,552.995 | 0 | 0 | 0 | 0 |
| EPS
| -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| EPS Diluted
| -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
| EBITDA
| -26.462 | -35.221 | -36.799 | -23.005 | -12.134 | -10.842 | -10.904 | -18.625 | -9.194 | -1.713 | -1.338 | -0.002 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -85,829.493 | 0 | 0 | 0 | 0 |